Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blink Contacts Lubricating Eye Drops is a sterile, isotonic ophthalmic solution designed to relieve dryness and discomfort associated with contact lens wear. In clinical research, specifically in trials sponsored by CooperVision (such as NCT02154399), it has served as the active control/comparator for evaluating new rewetting drop formulations. The product's primary active component is sodium hyaluronate, a viscoelastic glycosaminoglycan that mimics natural tears to provide long-lasting lubrication and hydration. The formulation is compatible with all soft contact lenses and includes the OcuPure preservative, which dissipates into natural tear components upon exposure to light, reducing the risk of preservative-induced irritation. It is widely used to improve the wearing experience for symptomatic contact lens users by stabilizing the tear film and reducing friction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Blink Contacts Lubricating Eye Drops (Johnson & Johnson).